NCT07474961 2026-03-16
BLOOD-dose
Rigshospitalet, Denmark
Phase 4 Not yet recruiting
Clinical Trials
13 trialsNCT07257484 2026-03-13
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
Weill Medical College of Cornell University
Phase 4 Not yet recruiting
NCT07469202 2026-03-13
CYTALUX Dose Extension Study
On Target Laboratories, LLC
Phase 4 Not yet recruiting
NCT07469488 2026-03-13
AmiCARE
Shanghai Pulmonary Hospital, Shanghai, China
Phase 4 Not yet recruiting
NCT07467174 2026-03-12
REPROG-RCT
Yonsei University
Phase 4 Not yet recruiting
NCT07459543 2026-03-09
A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India
Bristol-Myers Squibb
Phase 4 Not yet recruiting
NCT07221838 2026-03-03
OCTAGON
Alexion Pharmaceuticals, Inc.
Phase 4 Not yet recruiting
NCT07446465 2026-03-03
FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer
Fudan University
Phase 4 Not yet recruiting
NCT07436663 2026-02-27
SGLT2i/DPPi
Tanta University
Phase 4 Not yet recruiting
NCT07278362 2026-02-23
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
University of Miami
Phase 4 Not yet recruiting
NCT07426484 2026-02-23
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Phase 4 Not yet recruiting
NCT07281547 2026-02-18
Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain
Mayo Clinic
Phase 4 Not yet recruiting
NCT07412873 2026-02-17
PROVIDENCE
Fundacion Clinic per a la Recerca Biomédica
Phase 4 Not yet recruiting